564 related articles for article (PubMed ID: 11895935)
21. Induction of protective immunity against Streptococcus mutans colonization after mucosal immunization with attenuated Salmonella enterica serovar typhimurium expressing an S. mutans adhesin under the control of in vivo-inducible nirB promoter.
Huang Y; Hajishengallis G; Michalek SM
Infect Immun; 2001 Apr; 69(4):2154-61. PubMed ID: 11254570
[TBL] [Abstract][Full Text] [Related]
22. Mucosal immunization with an unadjuvanted vaccine that targets Streptococcus pneumoniae PspA to human Fcγ receptor type I protects against pneumococcal infection through complement- and lactoferrin-mediated bactericidal activity.
Bitsaktsis C; Iglesias BV; Li Y; Colino J; Snapper CM; Hollingshead SK; Pham G; Gosselin DR; Gosselin EJ
Infect Immun; 2012 Mar; 80(3):1166-80. PubMed ID: 22158740
[TBL] [Abstract][Full Text] [Related]
23. Enhancement of immune responses by an attenuated Salmonella enterica serovar Typhimurium strain secreting an Escherichia coli heat-labile enterotoxin B subunit protein as an adjuvant for a live Salmonella vaccine candidate.
Hur J; Lee JH
Clin Vaccine Immunol; 2011 Feb; 18(2):203-9. PubMed ID: 21159921
[TBL] [Abstract][Full Text] [Related]
24. Regulated delayed expression of rfc enhances the immunogenicity and protective efficacy of a heterologous antigen delivered by live attenuated Salmonella enterica vaccines.
Kong Q; Liu Q; Jansen AM; Curtiss R
Vaccine; 2010 Aug; 28(37):6094-103. PubMed ID: 20599580
[TBL] [Abstract][Full Text] [Related]
25. A comparison of immunogenicity and protective immunity against experimental plague by intranasal and/or combined with oral immunization of mice with attenuated Salmonella serovar Typhimurium expressing secreted Yersinia pestis F1 and V antigen.
Liu WT; Hsu HL; Liang CC; Chuang CC; Lin HC; Liu YT
FEMS Immunol Med Microbiol; 2007 Oct; 51(1):58-69. PubMed ID: 17640293
[TBL] [Abstract][Full Text] [Related]
26. Oral immunization with recombinant Salmonella typhimurium expressing surface protein antigen A of Streptococcus sobrinus: persistence and induction of humoral responses in rats.
Redman TK; Harmon CC; Michalek SM
Infect Immun; 1994 Aug; 62(8):3162-71. PubMed ID: 8039885
[TBL] [Abstract][Full Text] [Related]
27. Effect of deletion of genes involved in lipopolysaccharide core and O-antigen synthesis on virulence and immunogenicity of Salmonella enterica serovar typhimurium.
Kong Q; Yang J; Liu Q; Alamuri P; Roland KL; Curtiss R
Infect Immun; 2011 Oct; 79(10):4227-39. PubMed ID: 21768282
[TBL] [Abstract][Full Text] [Related]
28. Protection against nasal colonization with Streptococcus pneumoniae by parenteral immunization with a DNA vaccine encoding PspA (Pneumococcal surface protein A).
Ferreira DM; Oliveira ML; Moreno AT; Ho PL; Briles DE; Miyaji EN
Microb Pathog; 2010 Jun; 48(6):205-13. PubMed ID: 20206678
[TBL] [Abstract][Full Text] [Related]
29. Development of a conjugate vaccine against invasive pneumococcal disease based on capsular polysaccharides coupled with PspA/family 1 protein of Streptococcus pneumoniae.
Lin H; Peng Y; Lin Z; Zhang S; Guo Y
Microb Pathog; 2015; 83-84():35-40. PubMed ID: 25959527
[TBL] [Abstract][Full Text] [Related]
30. Genetic immunization with the region encoding the alpha-helical domain of PspA elicits protective immunity against Streptococcus pneumoniae.
Bosarge JR; Watt JM; McDaniel DO; Swiatlo E; McDaniel LS
Infect Immun; 2001 Sep; 69(9):5456-63. PubMed ID: 11500417
[TBL] [Abstract][Full Text] [Related]
31. [Characterization of attenuated Salmonella C500 strain with a delta asd mutant and use as an Asd+ balanced-lethal host-vector system].
Zhao Z; Xu Y; Wu B; Cheng X; Li Y; Tang X; Zhang C; Chen H
Sheng Wu Gong Cheng Xue Bao; 2009 Jan; 25(1):29-36. PubMed ID: 19441223
[TBL] [Abstract][Full Text] [Related]
32. Oral immunization with recombinant Salmonella typhimurium expressing surface protein antigen A (SpaA) of Streptococcus sobrinus: effects of the Salmonella virulence plasmid on the induction of protective and sustained humoral responses in rats.
Redman TK; Harmon CC; Michalek SM
Vaccine; 1996 Jun; 14(9):868-78. PubMed ID: 8843628
[TBL] [Abstract][Full Text] [Related]
33. Immunogenicity of recombinant attenuated Salmonella enterica serovar Typhimurium vaccine strains carrying a gene that encodes Eimeria tenella antigen SO7.
Konjufca V; Jenkins M; Wang S; Juarez-Rodriguez MD; Curtiss R
Infect Immun; 2008 Dec; 76(12):5745-53. PubMed ID: 18809658
[TBL] [Abstract][Full Text] [Related]
34. A bivalent conjugate vaccine containing PspA families 1 and 2 has the potential to protect against a wide range of Streptococcus pneumoniae strains and Salmonella Typhi.
Kothari N; Kothari S; Choi YJ; Dey A; Briles DE; Rhee DK; Carbis R
Vaccine; 2015 Feb; 33(6):783-8. PubMed ID: 25545593
[TBL] [Abstract][Full Text] [Related]
35. Two Novel
Zhao X; Dai Q; Jia R; Zhu D; Liu M; Wang M; Chen S; Sun K; Yang Q; Wu Y; Cheng A
Front Cell Infect Microbiol; 2017; 7():391. PubMed ID: 28929089
[TBL] [Abstract][Full Text] [Related]
36. Protective Immune Responses Elicited by Fusion Protein Containing PsaA and PspA Fragments.
Lu J; Sun T; Wang D; Dong Y; Xu M; Hou H; Kong FT; Liang C; Gu T; Chen P; Sun S; Lv X; Jiang C; Kong W; Wu Y
Immunol Invest; 2015; 44(5):482-96. PubMed ID: 26107747
[TBL] [Abstract][Full Text] [Related]
37. PsaA (pneumococcal surface adhesin A) and PspA (pneumococcal surface protein A) DNA vaccines induce humoral and cellular immune responses against Streptococcus pneumoniae.
Miyaji EN; Dias WO; Gamberini M; Gebara VC; Schenkman RP; Wild J; Riedl P; Reimann J; Schirmbeck R; Leite LC
Vaccine; 2001 Dec; 20(5-6):805-12. PubMed ID: 11738744
[TBL] [Abstract][Full Text] [Related]
38. Immunological responses induced by asd and wzy/asd mutant strains of Salmonella enterica serovar Typhimurium in BALB/c mice.
Piao HH; Tam VT; Na HS; Kim HJ; Ryu PY; Kim SY; Rhee JH; Choy HE; Kim SW; Hong Y
J Microbiol; 2010 Aug; 48(4):486-95. PubMed ID: 20799091
[TBL] [Abstract][Full Text] [Related]
39. Optimized immune response elicited by a DNA vaccine expressing pneumococcal surface protein a is characterized by a balanced immunoglobulin G1 (IgG1)/IgG2a ratio and proinflammatory cytokine production.
Ferreira DM; Darrieux M; Oliveira ML; Leite LC; Miyaji EN
Clin Vaccine Immunol; 2008 Mar; 15(3):499-505. PubMed ID: 18184825
[TBL] [Abstract][Full Text] [Related]
40. DNA vaccines expressing pneumococcal surface protein A (PspA) elicit protection levels comparable to recombinant protein.
Ferreira DM; Miyaji EN; Oliveira MLS; Darrieux M; Arêas APM; Ho PL; Leite LCC
J Med Microbiol; 2006 Apr; 55(Pt 4):375-378. PubMed ID: 16533983
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
